| Microorganism |  |  |  | 
  
    | Antimicrobial |  |  | Reference | 
            
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 0.25 - 2 | Vancomycin (Vancocyn, Lyphocin)  | 207 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 0.5 - 2 | Vancomycin (Vancocyn, Lyphocin)  | 89 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 0.5 - 2 | Vancomycin (Vancocyn, Lyphocin)  | 73 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 0.5 - 2 | Vancomycin (Vancocyn, Lyphocin)  | 72 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 1 - 2 | Linezolid (PNU-100766, U-100766, Zyvox)  | 73 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 1 - 4 | Linezolid (PNU-100766, U-100766, Zyvox)  | 72 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 2 | 1 - 4 | Linezolid (PNU-100766, U-100766, Zyvox)  | 207 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 4 | 0.12 - 16 | Teicoplanin (Targocid)  | 67 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 4 | ≤0.12 - 16 | Teicoplanin (Targocid)  | 162 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 8 | 0.125 - 16 | Teicoplanin (Targocid)  | 207 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 8 | 0.25 - 16 | Teicoplanin (Targocid)  | 72 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 1 | 16 | 0.03 - 64 | Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin)  | 178 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 2 | 0.25 - 4 | Oritavancin (LY333328)  | 207 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 2 | 0.5 - 2 | Oritavancin (LY333328)  | 72 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 2 | 0.5 - 4 | Vancomycin (Vancocyn, Lyphocin)  | 67 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 2 | 0.5 - 4 | Vancomycin (Vancocyn, Lyphocin)  | 67 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 4 | 0.5 - 4 | Meticillin (Methicillin, Staphcillin)  | 178 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 8 | ≤0.06 - 16 | Ceftriaxone (Rocephin)  | 371 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 8 | ≤0.12 - 16 | Teicoplanin (Targocid)  | 73 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 16 | 0.25 - >32 | Ceftriaxone (Rocephin)  | 102 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 2 | 16 | 0.5 - 128 | Ampicillin (Omnipen)  | 1464 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 4 | 64 | ≤0.12 - 128 | Piperacillin (Pipracil)  | 89 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 8 | 32 | 8 - 64 | Mannopeptimycins (γ)  | 89 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 16 | 32 | 8 - >128 | D-ofloxacin  | 117 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | 64 | 64 | 4 - 128 | Thymol  | 1464 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | - | 0.12 | ? - ? | Ceftaroline  | 1358 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | - | 1.5 | ? - ? | Linezolid (PNU-100766, U-100766, Zyvox)  | 1112 | 
                
			        
			            | Staphylococci (coagulase-negative + methicillin-susceptible) | - | 2 | ? - ? | Linezolid (PNU-100766, U-100766, Zyvox)  | 1358 |